Lipid-based nanoparticles |
-
●
Low cytotoxicity
●Long long-circulating and high bioavailability
●Diversity and scale-up feasibility
●High transfection activity
|
|
Polymeric nanoparticles |
|
|
Gold nanoparticles |
●Molecular sensing feasibility based on the localized surface plasmon resonance
●Tunability of size and shape
●Photothermal effect
●Easy surface functionalization
|
●Non-degradable
●Slow body clearance
●Nanotoxicity
|
Porous nanomaterials |
●Structure homogeneity with large active surface area
●Controllable porosity
●High drug-loading capacity
●Capacity to obtain gated supports for on‐demand TOs delivery
|
|
DNA/RNA nanoassembly |
●Programmability and predictability in TOs loading
●TOs themselves are also building blocks
●Precise structures with addressable modification sites
|
●High expenses
●Nuclease degradation
|
Extracellular Vesicles |
●Good biocompatibility and low immunogenicity
●Tumor-homing ability and capacity to cross biological barriers
●Superior delivery efficiency
●Tunable surface receptors for site-specific delivery
|
|